Tech Company Financing Transactions

AdvanDx Funding Round

AdvanDx, based in Woburn, secured $8 million from SLS Invest AB and private investors.

Transaction Overview

Company Name
Announced On
8/18/2009
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series C
Investors

SLS Invest AB (Hans Andreasson)

Proceeds Purpose
The funding will be used to fund the expansion of AdvanDx's molecular diagnostics product offering as well as its international sales and marketing activities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Trade Ctr. 6990
Woburn, MA 01801
USA
Email Address
Overview
Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes.
Profile
AdvanDx LinkedIn Company Profile
Social Media
AdvanDx Company Twitter Account
Company News
AdvanDx News
Facebook
AdvanDx on Facebook
YouTube
AdvanDx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dennis Langer
  Dennis Langer LinkedIn Profile  Dennis Langer Twitter Account  Dennis Langer News  Dennis Langer on Facebook
Chief Financial Officer
Tucker Kelly
  Tucker Kelly LinkedIn Profile  Tucker Kelly Twitter Account  Tucker Kelly News  Tucker Kelly on Facebook
VP - Bus. Development
James Coull
  James Coull LinkedIn Profile  James Coull Twitter Account  James Coull News  James Coull on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/18/2009: Polyvore venture capital transaction
Next: 8/18/2009: Jambool venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary